Regents Professor is the highest faculty award possible at Arizona’s state universities and is conveyed by the Arizona Board of Regents.
Hao Yan is director of the Biodesign Center for Molecular Design and Biomimetics and the Milton D. Glick Distinguished Professor in the School of Molecular Sciences at Arizona State University.Continue reading
[Phoenix, AZ] — November 22nd, 2024 — The Pause Technologies Inc., the company behind the innovative menopause management platform thePause™, has been awarded first place in the prestigious HITLAB x Versalie™ Innovation Challenge. Selected from hundreds of innovative submissions, this accolade highlights thePause™’s mission to make menopause support accessible and personalized through their digital health platform. The company will receive a $25,000 prize to continue advancing its impactful work.Continue reading
Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYN in skin biopsies using CND’s Syn-One Test®Continue reading
Washington, D.C. – AdvaMed, the Medtech Association, today welcomed introduction in the U.S. Senate of bipartisan legislation to expedite Medicare coverage of FDA-“breakthrough”-designated medical technologies and diagnostic tests. The legislation, the Ensuring Patient Access to Critical Breakthrough Products Act, introduced by Sen. Todd Young (R-IN) and Sen. Alex Padilla (D-CA), is similar to H.R. 1691, which the U.S. House of Representatives Ways and Means Committee passed on a bipartisan basis in June. Continue reading
Tucson, AZ, Nov 20, 2024, SynCardia Systems, LLC., a Picard Medical Inc. company, is proud to announce that it has surpassed the 2,100-patient mark of SynCardia Total Artificial Hearts implants.Continue reading
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B. Helmsley Charitable Trust, a new research grant aimed at developing a novel treatment for type 1 diabetes (T1D). This award is made through TRxA’s Bridging Research and Innovation in Drug Development Grants (BRIDGe) program, which is designed to support academic researchers in traversing the drug development valley of death and advancing new cutting-edge therapeutics from the lab to patients. Continue reading
HonorHealth Research Institute study looks for ways to prevent or reduce nerve damage in pancreatic cancer patients treated with chemotherapyContinue reading
As biotech breakthroughs enable remarkable advances in treatment and prevention of disease, we need similar levels of innovation in access, so patients benefit from these breakthroughs, John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), told the Milken Institute’s Future of Health Summit.Continue reading
Such an algorithm may save clinicians time and accelerate clinical enrollment and research.Continue reading
Paradise Valley High School CREST Biotech Sustainability teacher, Michelle Landreville, was honored as the 2024 Teacher of the Year at the Governor’s Celebration of Innovation presented by the Arizona Technology Council and Arizona Commerce Authority. Continue reading